1.
Farris SG, McLean CP, Van Meter PE, Simpson HB, Foa EB: Treatment response, symptom remission and wellness in obsessive-compulsive disorder. J Clin Psychiatry 2013;74:685-690.
2.
Simpson HB, Maher MJ, Wang Y, Bao Y, Foa EB, Franklin M: Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder. J Consult Clin Psychol 2011;79:247-252.
3.
Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD: Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci 2012;16:81-91.
4.
Kalanthroff E, Henik A: Individual but not fragile: individual differences in task control predict Stroop facilitation. Conscious Cogn 2013;22:413-419.
5.
Kalanthroff E, Henik A, Simpson HB, Todder D, Anholt GE: To do or not to do? Task control deficit in obsessive-compulsive disorder. Behav Ther 2017;48:603-613.
6.
Kozak MJ, Foa EB: Mastery of Obsessive-Compulsive Disorder. New York, Oxford University Press, 1997.
7.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.
8.
Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis PM: The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assessment 2002;14:485-496.
9.
Obsessive Compulsive Cognitions Working Group: Psychometric validation of the obsessive belief questionnaire and interpretation of intrusions inventory. 2. Factor analyses and testing of a brief version. Behav Res Ther 2005;43:1527-1542.
10.
Beck AT, Steer RA, Brown GK: Beck Depression Inventory-II. San Antonio, Psychological Corporation, 1996, vol 78, pp 490-498.
11.
Kalanthroff E, Davelaar EJ, Henik A, Goldfarb L, Usher M: Task conflict and proactive control: a computational theory of the Stroop task. Psychol Rev, DOI: 10.1037/rev0000083.
12.
Verbruggen F, Logan GD, Stevens MA: STOP-IT: Windows executable software for the stop-signal paradigm. Behav Res Methods 2008;40:479-483.
13.
Lang PJ, Bradley MM, Cuthbert BN: International Affective Picture System (IAPS): Affective Ratings of Pictures and Instruction Manual. Technical Report A-8. Gainesville, University of Florida, 2008.
14.
Kalanthroff E, Henik A, Derakshan N, Usher M: Anxiety, emotional distraction, and attentional control in the Stroop task. Emotion 2016;16: 293-300.
© 2016 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the...
© 2016 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.